
Overview
Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009.
Dr. Kates is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.
Dr. Kates is board certified in American Board Of Urology. He is actively involved in clinical research, co-authoring 165 peer reviewed articles and participating in 3 clinical trials. Dr. Kates is currently accepting new patients.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 4, Floor 4, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Johns Hopkins Outpatient Center
Dr. Misop Han is David Hall McConnell Professor of Urology and Oncology at the Johns Hopkins School of Medicine. Dr. Han is a urologist whose main clinical focus is in urological oncology with a special emphasis on prostate and kidney cancers. He specializes in robotic nerve-sparing prostatectomy and robotic nephrectomy. Dr. Han received his undergraduate and medical degrees at Johns Hopkins. After an internship in surgery and residency in urology, also at Johns Hopkins, he worked as faculty at Northwestern University and Hospital in Chicago, Illinois. In 2006, he joined the Johns Hopkins faculty. His research interests include the outcome of radical prostatectomy, medical robotics and prediction modeling (what happens to men following surgery for prostate cancer). He has published extensively in these subjects and has received international and national recognition for his research. He is actively involved in several clinical research projects with the database of more than 20,000 men who received surgery for prostate cancer at The Johns Hopkins Hospital. He is a member of the American Urological Association and the American Medical Association. Dr. Han is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Ureterocele, Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Han is board certified in American Board Of Urology. Dr. Han is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine. Dr. Holdhoff is currently accepting new patients.
Stoler Outpatient Cancer Clinic
Taofeek Owonikoko is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Owonikoko is currently accepting new patients.
Frequently Asked Questions about Dr. Max R. Kates
How do I make an appointment with Dr. Max R. Kates?
You can book an appointment with Dr. Max R. Kates by calling their office at 410-955-6100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Max R. Kates a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Max R. Kates is classified as an Elite expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Max R. Kates specialize in?
While Dr. Max R. Kates is a Oncology, they have specific expertise in Bladder Cancer, Urothelial Cancer, and Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Max R. Kates participate in research or clinical trials?
Yes. Dr. Max R. Kates has published 165 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Max R. Kates's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Max R. Kates accept my insurance?
Dr. Max R. Kates accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-955-6100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Kates isElite. Learn about Bladder Cancer.
- CystectomyDr. Kates isElite. Learn about Cystectomy.
- Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Cancer
- Urothelial CancerDr. Kates isElite. Learn about Urothelial Cancer.
- Distinguished
- NephrectomyDr. Kates isDistinguished. Learn about Nephrectomy.
- Advanced
- EndoscopyDr. Kates isAdvanced. Learn about Endoscopy.
- Erectile Dysfunction (ED)Dr. Kates isAdvanced. Learn about Erectile Dysfunction (ED).
- LymphadenectomyDr. Kates isAdvanced. Learn about Lymphadenectomy.
- MalakoplakiaDr. Kates isAdvanced. Learn about Malakoplakia.
- Prostate CancerDr. Kates isAdvanced. Learn about Prostate Cancer.
- ProstatectomyDr. Kates isAdvanced. Learn about Prostatectomy.
- Renal Cell Carcinoma (RCC)Dr. Kates isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Upper Tract Urothelial Carcinoma (UTUC)
- Experienced
- Adult Soft Tissue SarcomaDr. Kates isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bilateral HydronephrosisDr. Kates isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder ReconstructionDr. Kates isExperienced. Learn about Bladder Reconstruction.
- Chromophobe Renal Cell CarcinomaDr. Kates isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Kates isExperienced. Learn about Clear Cell Sarcoma.
- Enlarged Prostate (BPH)Dr. Kates isExperienced. Learn about Enlarged Prostate (BPH).
- Familial Prostate CancerDr. Kates isExperienced. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Kates isExperienced. Learn about Familial Wilms Tumor 2.
- Hemolytic Transfusion ReactionDr. Kates isExperienced. Learn about Hemolytic Transfusion Reaction.
- HydronephrosisDr. Kates isExperienced. Learn about Hydronephrosis.
- Intussusception in ChildrenDr. Kates isExperienced. Learn about Intussusception in Children.
- Obstructive UropathyDr. Kates isExperienced. Learn about Obstructive Uropathy.
- Partial Androgen Insensitivity Syndrome (PAIS)
- Pelvic Inflammatory DiseaseDr. Kates isExperienced. Learn about Pelvic Inflammatory Disease.
- PriapismDr. Kates isExperienced. Learn about Priapism.
- Reconstructive Urology SurgeryDr. Kates isExperienced. Learn about Reconstructive Urology Surgery.
- Retroperitoneal FibrosisDr. Kates isExperienced. Learn about Retroperitoneal Fibrosis.
- UPJ ObstructionDr. Kates isExperienced. Learn about UPJ Obstruction.
- Urachal CancerDr. Kates isExperienced. Learn about Urachal Cancer.
- Urachal CystDr. Kates isExperienced. Learn about Urachal Cyst.
- UreteroceleDr. Kates isExperienced. Learn about Ureterocele.
- UreteroscopyDr. Kates isExperienced. Learn about Ureteroscopy.
- Urinary Tract Infection (UTI)Dr. Kates isExperienced. Learn about Urinary Tract Infection (UTI).
- VasectomyDr. Kates isExperienced. Learn about Vasectomy.
- Wilms TumorDr. Kates isExperienced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Kates isExperienced. Learn about WT1-Related Wilms Tumor Syndromes.

